Here’s Why BioXcel Therapeutics Stock Got Hammered This Week
Investors weren’t happy about a secondary share offering.
Investors weren’t happy about a secondary share offering.
Let’s just say that this thriller about big-rig haulers navigating slippery, frosty terrain is on thin ice in more…
During the last two decades, technological innovation and regulatory requirements have deeply changed the way financial markets…
On June 15, Aima Technology (SHA:603529), a leading Chinese e-bike manufacturer, announced its Initial Public Offering (IPO)…
Stock prices move based on what a company earns and stories about what that company will earn in the…
We urge investors to take profits as UiPath shares will likely contract from current levels driven by lockup expiration,…
After a long run of strong earnings, FedEx disappointed some analysts by coming in just a few cents above…
This past week, the effective federal funds rate rose for the first time this year, reflecting Fed efforts to…
After a six-day losing streak that led the company to lose nearly a fifth of its value, the maker…
The Thyrocare stock surged 6.23% to ₹1,448.05 on BSE. The announcement was made after the end of trading…